MOG antibody disease (MOGAD)

MOG antibody disease (MOGAD) is a recently coined neuro-inflammatory condition that preferentially causes inflammation in the optic nerve but can also cause inflammation in the spinal cord and brain. Myelin oligodendrocyte glycoprotein (MOG) is a protein that is located on the surface of myelin sheaths in the central nervous system. While the function of this glycoprotein is not exactly known, MOG is a target of the immune system in this disease.The diagnosis is confirmed when MOG antibodies in the blood are found in patients who have repeated inflammatory attacks of the central nervous system.

  • Neuromyelitis Optica Spectrum Disorder (NMOSD)
  • Transverse Myelitis (TM)
  • Optic Neuritis (ON)
  • Acute Disseminated Encephalomyelitis (ADEM)

Related Conference of MOG antibody disease (MOGAD)

September 18-19, 2026

21st Annual Congress on Neuroscience

Dubai, UAE
November 16-17, 2026

8th World Brain Congress

Tokyo, Japan
November 23-24, 2026

16th Global Alzheimers Summit

Paris, France
November 24-25, 2026

38th World Conference on Neurology

Rome, Italy
December 16-17, 2026

12th International Conference on Brain Injury & Neuro Surgeons

Amsterdam, Netherlands
December 21-22, 2026

6th International Conference on Child Neurology

Paris, France
December 28-29, 2026

18th Global Neurologists Meeting on Neurology and Neurosurgery

Amsterdam, Netherlands
December 28-29, 2026

39th European Neurology Congress

Amsterdam, Netherlands
March 22-23, 2027

8th International Conference on Neurologists

Singapore City, Singapore
March 24-25, 2027

38th Conference on Clinical Neuroscience and Neurogenetics

Geneva, Switzerland

MOG antibody disease (MOGAD) Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in